ADMiER the one-step point-of-care test to rapidly and accurately diagnose dry eye

Dry eye is a highly prevalent condition and about 3.5 million Australians suffer from the symptoms. The economic burden is estimated at $1.2 billion per year.

Currently, there is no single diagnostic device for accurate and efficient triaging of patients with ocular discomfort symptoms. Instead, clinicians must rely on a battery of tests that are time consuming, suffer from poor precision, and are invasive for patients.

The technology, ADMiER, is unique, providing a one-step, point-of-care test to rapidly and accurately diagnose dry eye. It is the only test to objectively and non-invasively diagnose, stratify and sub-type dry eye disease. It has a sensitivity of 80% and specificity of 86%.

The device is a transformative advance over traditional techniques and the researchers foresee it becoming the “go to” tear film diagnostic for eye care clinicians. Societal benefit will result from more efficient patient triaging (with time savings for clinicians and economic gains relating to reduced healthcare costs). Patients will benefit from enhanced diagnosis, as this will lead to more well informed dry eye treatment, leading to improved health outcomes.